Akero Therapeutics: Cirrhosis Reversal Data Derisks The Stock
Discover how Akero Therapeutics' EFX outshines competitors in MASH treatment, with groundbreaking results and strong ...
Corebridge Financial Inc. Decreases Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO)
Corebridge Financial Inc. lowered its position in shares of Akero Therapeutics, Inc. (NASDAQ:AKRO – Free Report) by 7.0% in ...
BioSpace1d
7 Late-Stage MASH Candidates That Could Reshape the Market
Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic dysfunction-associated steatohepatitis to a market that could reach $16 billion by ...
Nasdaq6d
Akero Therapeutics Enters Oversold Territory (AKRO)
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Tuesday, shares of Akero Therapeutics Inc (Symbol: AKRO) entered into oversold territory, hitting an RSI ...
Business Insider4d
Bronstein, Gewirtz & Grossman, LLC Is Investigating Akero Therapeutics, Inc. (AKRO) And Encourages Shareholders to Connect
NEW YORK CITY, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Akero Therapeutics, Inc. ("Akero" or "the ...
24/7 Wall St. on MSN5d
Insiders Are Loving These 5 Tech and Biotech Stocks
Insiders have lately been showing their love for these three biotech stocks, two tech stocks, and a utility stock with huge ...
Yahoo Finance4d
Akero Therapeutics, Inc. (0K4.F)
At close: April 4 at 8:00:34 a.m. GMT+2 Loading Chart for 0K4.F ...
Nasdaq6d
Akero Therapeutics, Inc. Common Stock (AKRO) Earnings
Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...